Nabumetone
- Product NDC
- 71205-530
- 11-digit product format
- 712050530
- Labeler code
- 71205
- Product ID
- 71205-530_143af59b-1513-46bd-8f77-63c04bdbd07c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2019-06-26
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| LW0TIW155Z | NABUMETONE | 42924-53-8 | NABUMETONE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71205-530-30 | 71205053030 | 30 TABLET in 1 BOTTLE (71205-530-30) | 30 tablet | 2021-02-03 | No | No | Historical |
| 71205-530-60 | 71205053060 | 60 TABLET in 1 BOTTLE (71205-530-60) | 60 tablet | 2021-02-03 | No | No | Historical |
| 71205-530-90 | 71205053090 | 90 TABLET in 1 BOTTLE (71205-530-90) | 90 tablet | 2021-02-03 | No | No | Historical |